Leerink Partners analyst Michael Cherny has maintained their bullish stance on CAH stock, giving a Buy rating on January 15.Stay Ahead of the ...

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) yesterday and set a price ...

Michelle Greene leads with emphathy. She believes that has been her secret sauce in forging productive bonds across her ...

The company said the new DC will support its at-Home Solutions business and improve the delivery of medical supplies to ...

Valued at a market cap of $29.4 billion, Cardinal Health, Inc. (CAH) is a healthcare services and products company that ...

Cardinal Health’s profit margin lags behind peers, impacting growth. See why CAH stock’s outlook may be hindered by legal ...

The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is ...

Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Cardinal Health (NYSE:CAH) from Neutral ...

Czech National Bank boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.6% during the fourth ...

BofA upgrades Cardinal Health to Buy, citing faster growth in ... driven by a shift toward private-label products and a growing focus on specialty services. The analyst notes the price target ...

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care ...